Evidence map›Paper›PMID 26150117›Full record

ArticleBMC bioinformatics2015

VISA--Vector Integration Site Analysis server: a web-based server to rapidly identify retroviral integration sites from next-generation sequencing.

Jonah D Hocum, Logan R Battrell, Ryan Maynard, Jennifer E Adair, Brian C Beard, David J Rawlings, Hans-Peter Kiem, Daniel G Miller, Grant D Trobridge

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Interrogation of clonal tracking data usingNature computational science · 2021
    Article
  6. Human gene therapy · 2021
    Article
  7. Article
  8. VSeq-Toolkit: Comprehensive Computational Analysis of Viral Vectors in Gene Therapy.Molecular therapy. Methods & clinical development · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. In Vivo Murine-Matured Human CD3Molecular therapy. Methods & clinical development · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jonah D HocumDepartment of Pharmaceutical Sciences, Washington State University, Spokane, WA, 99210, USA. jhocum@wsu.edu.
Logan R BattrellDepartment of Pharmaceutical Sciences, Washington State University, Spokane, WA, 99210, USA. logan_battrell@wsu.edu.
Ryan MaynardDepartment of Pharmaceutical Sciences, Washington State University, Spokane, WA, 99210, USA. ryan.maynard@wsu.edu.
Jennifer E AdairClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA. jadair@fhcrc.org.
Brian C BeardClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA. bbeard@fhcrc.org.
David J RawlingsDepartment of Pediatrics, University of Washington, Seattle, WA, 98195, USA. drawling@uw.edu.
Hans-Peter KiemClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA. hkiem@fhcrc.org.
Daniel G MillerDepartment of Pediatrics, University of Washington, Seattle, WA, 98195, USA. dgmiller@uw.edu.
Grant D TrobridgeDepartment of Pharmaceutical Sciences, Washington State University, Spokane, WA, 99210, USA. grant.trobridge@wsu.edu.
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAWashington State University Spokane · USWashington State University · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Vector ProductionP01AI097100 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI BEARD, BRIAN C · 2012 to 2016
$11.9M
Improved Foamy Virus Vectors for AIDS Gene TherapyR01AI102672 · NIAID · WASHINGTON STATE UNIVERSITY · PI TROBRIDGE, GRANT D · 2013 to 2017
$1.8M
Keratin Gene Targeting for the Treatment of Epidermolysis BullosaR01AR055941 · NIAMS · UNIVERSITY OF WASHINGTON · PI MILLER, DANIEL G · 2010 to 2014
$1.6M
Mutagenesis Screen for Prostate CancerR15CA173598 · NCI · WASHINGTON STATE UNIVERSITY · PI TROBRIDGE, GRANT D · 2013 to 2013
$418k
NCI NIH HHS CA173598NCI NIH HHS R15 CA173598NIAID NIH HHS AI097100NIAID NIH HHS AI102672NIAID NIH HHS P01 AI097100NIAID NIH HHS R01 AI102672NIAMS NIH HHS R01 AR055941NIH HHS P51 OD010425
6 · The paper itself

Abstract

backgroundAnalyzing the integration profile of retroviral vectors is a vital step in determining their potential genotoxic effects and developing safer vectors for therapeutic use. Identifying retroviral vector integration sites is also important for retroviral mutagenesis screens.

resultsWe developed VISA, a vector integration site analysis server, to analyze next-generation sequencing data for retroviral vector integration sites. Sequence reads that contain a provirus are mapped to the human genome, sequence reads that cannot be localized to a unique location in the genome are filtered out, and then unique retroviral vector integration sites are determined based on the alignment scores of the remaining sequence reads.

conclusionsVISA offers a simple web interface to upload sequence files and results are returned in a concise tabular format to allow rapid analysis of retroviral vector integration sites.

Indexed as

Genetic VectorsGenome, HumanInternetSoftwareHigh-Throughput Nucleotide SequencingHumansRetroviridaeVirus Integration

Identifiers

PMID26150117
PMCPMC4493804
OpenAlexW1801876314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.